This public procurement record has 2 releases in its history.

Planning

05 Aug 2026 at 12:07

Planning

03 Jul 2026 at 09:10

Summary of the contracting process

NHS England plans to procure trastuzumab 600mg subcutaneous injection through a national medicines framework. The requirement is for pharmaceutical products supplied to NHS organisations across England, covering the North East, North West, East Midlands, West Midlands, East of England, London, South East and South West. The procurement is managed by NHS England’s Medicines Procurement and Supply Chain team within NHS Medicines Value & Access. It concerns goods rather than services or works, and is intended to support NHS medicine supply nationally. Suppliers with a product matching the specified trastuzumab strength and subcutaneous presentation should assess whether they can support supply across the covered English regions. The framework is a single planned lot and has been identified as suitable for small and medium-sized enterprises.

This procurement is at the planning stage: NHS England has stated an intention to procure, but has not yet invited tenders. The expected procedure is an open procedure for a framework agreement. The planned framework period is 1 June 2027 to 31 August 2028, with options to extend by periods totalling up to 24 months, to a maximum date of 31 August 2030. The estimated value is £85.8 million excluding VAT, or £102.96 million including VAT. NHS England expects the next notice on 1 September 2026. It is holding virtual preliminary market engagement to discuss timelines, product details, launches during the framework period, tender structure and KPIs; suppliers are expected to register interest by 19 August 2026.

The planned framework is likely to suit pharmaceutical manufacturers, marketing authorisation holders, distributors and potential new entrants preparing to launch trastuzumab 600mg subcutaneous injection. NHS England is specifically seeking engagement with current suppliers and suppliers planning launches of the molecules covered by the procurement, so businesses should be able to demonstrate a credible product pipeline and understand launch timing during the proposed framework period. National coverage means suppliers should prepare for delivery and supply arrangements serving NHS organisations across England rather than a single local health economy. The buyer’s engagement will help shape product details, the tender structure and key performance indicators, giving prospective suppliers an opportunity to understand the intended requirements and prepare their technical, regulatory, manufacturing and distribution plans before the tender reaches the market.

How relevant is this notice?

Notice Title

NHS National Framework for Trastuzumab 600mg Subcutaneous Injection

Notice Description

Project title: NHS National Framework for Trastuzumab 600mg Subcutaneous Injection Offer reference number: CM/TNS/26/5762 Period of framework: 1 June 2027 to 31 August 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06c2f7
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/074125-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£85,800,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
5 Aug 20262 weeks ago
Submission Deadline
Not specified
Future Notice Date
1 Sep 20261 weeks to go
Award Date
Not specified
Contract Period
1 Jun 2027 - 31 Aug 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...